Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Coeptis Therapeutics Holdings, Inc. - Common Stock (NQ:COEP)

14.50 +0.07 (+0.49%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 165,553
Open 14.44
Bid (Size) 13.50 (100)
Ask (Size) 15.00 (1,700)
Prev. Close 14.43
Today's Range 13.82 - 14.88
52wk Range 2.622 - 21.41
Shares Outstanding 5,340,111
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Three Biotech Companies Redefining Value Creation Through Dual Strategies
Via ACCESS Newswire
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates BFIN, COEP, ARIS, CIO on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
+145.3%
+145.3%
1 Month
-4.3%
-4.3%
3 Month
+15.1%
+15.1%
6 Month
+87.8%
+87.8%
1 Year
+243.6%
+243.6%

More News

Read More
News headline image
Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
From Coeptis Therapeutics
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
From Coeptis Therapeutics
Via GlobeNewswire
News headline image
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
From Coeptis Therapeutics
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss ↗
Via Benzinga
News headline image
COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results ↗
Via Benzinga
Topics Stocks
News headline image
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
From Coeptis Therapeutics
Via GlobeNewswire
News headline image
COEPTIS (COEP) Expands Global Footprint with Strategic India Tech Hub
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
From Coeptis Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Top movers in Monday's after hours session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Coeptis (NASDAQ: COEP) Accelerates Growth with Strategic Partnerships and Innovation
Via AB Newswire
Topics Artificial Intelligence
News headline image
Coeptis Inc. (COEP) Expands Cancer Immunotherapy Portfolio with Exclusive GEAR Cell Therapy License
Via AB Newswire

Frequently Asked Questions

Is Coeptis Therapeutics Holdings, Inc. - Common Stock publicly traded?
Yes, Coeptis Therapeutics Holdings, Inc. - Common Stock is publicly traded.
What exchange does Coeptis Therapeutics Holdings, Inc. - Common Stock trade on?
Coeptis Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Coeptis Therapeutics Holdings, Inc. - Common Stock?
The ticker symbol for Coeptis Therapeutics Holdings, Inc. - Common Stock is COEP on the Nasdaq Stock Market
What is the current price of Coeptis Therapeutics Holdings, Inc. - Common Stock?
The current price of Coeptis Therapeutics Holdings, Inc. - Common Stock is 14.50
When was Coeptis Therapeutics Holdings, Inc. - Common Stock last traded?
The last trade of Coeptis Therapeutics Holdings, Inc. - Common Stock was at 12/17/25 04:00 PM ET
What is the market capitalization of Coeptis Therapeutics Holdings, Inc. - Common Stock?
The market capitalization of Coeptis Therapeutics Holdings, Inc. - Common Stock is 77.43M
How many shares of Coeptis Therapeutics Holdings, Inc. - Common Stock are outstanding?
Coeptis Therapeutics Holdings, Inc. - Common Stock has 77M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.